Amy Baxter MD is a Clinical Professor at Augusta University and CEO/Chief Science officer of two noninvasive neuromodulation device companies founded to eliminate unnecessary pain and opioid use. After graduating Yale and Emory Medical School and completing fellowships in Child Maltreatment, Emergency Medicine, and Clinical Research she founded a CHOA Pediatric Emergency Research program. Federally funded for multimodal mechanical stimulation (M-Stim) research, she publishes and lectures internationally on pain management, procedural sedation, and opioid alternatives. Contributions include the hepatic enzyme algorithm for timing child abuse, the validated BARF nausea scale, identifying the window and cause of needle fear, hypothesizing and prospectively demonstrating decreased COVID morbidity using nasal irrigation, and harmonic M-Stim interaction’s effect preventing and treating chronic nonspecific LBP. Service includes HHS testimony, extensive NIH SRG service, and the CDC ED Covid Task Force. Current research interests are the role of interactive frequencies and Pacininan neuromodulation on fascia and chronic pain. Inventions include VibraCool® Vibrational Cryotherapy and DuoTherm™ Interactive M-Stim Low Back Pain, pivotal trials published in 2025. She has 15+ patents, authored two successful 510k applications, and her 2023 TED talk “How your brain hacks pain” has >1.5M views. Best known for her Buzzy® device, blocking pain for over 250 million needle procedures worldwide.